Independent · Evidence-led · We don't sell peptides
EU / NordicsUpdated weeklyEN
#Injury recovery
BPC-157, TB-500, thymosin family and the grey-market injury-repair use case.
Explainer
What is KLOW? The peptide blend, explained
KLOW mixes BPC-157, TB-500, GHK-Cu, and KPV. Here is what the evidence for each ingredient shows, and why none of it answers a fracture-healing question.
Explainer
Peptide cycles per year: no number exists
Cycle lengths come from a few small trials. Cycle counts come from nowhere, because no study has tested repeating a peptide course across a year.
Explainer
A forum peptide dose is not a minimum
No human trial has established a minimum BPC-157 or TB-500 dose for repair. The familiar forum numbers come from animal work and estimates.
Explainer
Why you cannot tell which peptide did it
Running BPC-157, TB-500 and tirzepatide together makes every result uninterpretable. Here is why pharmacology treats one variable at a time.